You are here

Final Approval Granted for Generic Zithromax

PITTSBURGH, May 31 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE:MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Applications (ANDAs) for Azithromycin Tablets, 250 mg and 500 mg.

Azithromycin Tablets are the generic version of Pfizer's Zithromax(R) Tablets. Azithromycin Tablets had U.S. sales of approximately $886 million for the 12 months ending March 31, 2007, for the same strengths.

This product will be shipped immediately.

Source: Mylan Laboratories

Recent Headlines

Safety concerns include liver injury and interactions with other drugs
No tobacco product is safe, says the lung heath group
Discovery seen as possibly leading to new anti-TB drugs
Study points to permanent hair dye and straighteners
How malaria parasites evade first-line drugs
A new way to fight staph infections
Score could help prevent misuse among cancer patients